PLEKHS1 and breast cancer: We previously reported that non-coding mutations in PLEKHS1 and WDR74 are good prognostic indicators in a cohort of 302 BC patients, but that the non-coding mutations do not appear to alter the expression or splicing of any of the 5 genes6.